Philip LaRussa

6.1k total citations
123 papers, 3.9k citations indexed

About

Philip LaRussa is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Philip LaRussa has authored 123 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Epidemiology, 32 papers in Infectious Diseases and 31 papers in Virology. Recurrent topics in Philip LaRussa's work include Herpesvirus Infections and Treatments (51 papers), Poxvirus research and outbreaks (24 papers) and Respiratory viral infections research (20 papers). Philip LaRussa is often cited by papers focused on Herpesvirus Infections and Treatments (51 papers), Poxvirus research and outbreaks (24 papers) and Respiratory viral infections research (20 papers). Philip LaRussa collaborates with scholars based in United States, Uganda and United Kingdom. Philip LaRussa's co-authors include Anne A. Gershon, Sharon P. Steinberg, Sharon Steinberg, Iain R. B. Hardy, Saul J. Silverstein, Robert G. Sharrar, Kenneth Rich, William T. Shearer, A. A. Gershon and Octavian Lungu and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Philip LaRussa

121 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip LaRussa United States 35 2.8k 1.1k 1.1k 643 593 123 3.9k
Sandra S. Chaves United States 37 4.2k 1.5× 412 0.4× 1.3k 1.2× 420 0.7× 523 0.9× 138 5.4k
Adriana Weinberg United States 45 4.3k 1.5× 879 0.8× 1.2k 1.1× 241 0.4× 453 0.8× 234 6.3k
Rafael Harpaz United States 40 5.1k 1.8× 673 0.6× 1.3k 1.2× 333 0.5× 1.2k 2.0× 95 6.9k
Robin Broadhead Malawi 39 1.4k 0.5× 787 0.7× 2.4k 2.2× 236 0.4× 221 0.4× 108 4.9k
Barbara J. Kuter United States 31 3.0k 1.1× 439 0.4× 1.1k 1.1× 652 1.0× 372 0.6× 99 3.9k
Melinda Wharton United States 30 2.4k 0.9× 246 0.2× 1.4k 1.3× 356 0.6× 314 0.5× 67 4.0k
Anton M. van Loon Netherlands 47 4.9k 1.8× 279 0.2× 2.9k 2.7× 348 0.5× 475 0.8× 184 7.7k
Javier Díez‐Domingo Spain 34 3.6k 1.3× 198 0.2× 919 0.9× 200 0.3× 422 0.7× 220 4.7k
Aisha O. Jumaan United States 31 2.9k 1.0× 607 0.5× 893 0.8× 641 1.0× 908 1.5× 54 3.9k
Keith S. Reisinger United States 41 4.5k 1.6× 208 0.2× 1.1k 1.0× 382 0.6× 165 0.3× 108 6.0k

Countries citing papers authored by Philip LaRussa

Since Specialization
Citations

This map shows the geographic impact of Philip LaRussa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip LaRussa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip LaRussa more than expected).

Fields of papers citing papers by Philip LaRussa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip LaRussa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip LaRussa. The network helps show where Philip LaRussa may publish in the future.

Co-authorship network of co-authors of Philip LaRussa

This figure shows the co-authorship network connecting the top 25 collaborators of Philip LaRussa. A scholar is included among the top collaborators of Philip LaRussa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip LaRussa. Philip LaRussa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levasseur, Stéphanie, Philip LaRussa, Wilmot James, et al.. (2024). Infection prevention and control and related practices in African neonatal units: The Pan-African neonatal care assessment study (PANCAS). International Journal of Hygiene and Environmental Health. 259. 114357–114357.
2.
Russell, Kate, Ashley Fowlkes, Melissa S. Stockwell, et al.. (2018). Comparison of outpatient medically attended and community‐level influenza‐like illness—New York City, 2013‐2015. Influenza and Other Respiratory Viruses. 12(3). 336–343. 5 indexed citations
3.
Stockwell, Melissa S., Karen R. Broder, Paige Lewis, et al.. (2016). Assessing Fever Frequency After Pediatric Live Attenuated Versus Inactivated Influenza Vaccination. Journal of the Pediatric Infectious Diseases Society. 6(3). piw028–piw028. 7 indexed citations
4.
Mbonye, Anthony K., Esther Buregyeya, Elizeus Rutebemberwa, et al.. (2016). Prescription for antibiotics at drug shops and strategies to improve quality of care and patient safety: a cross-sectional survey in the private sector in Uganda. BMJ Open. 6(3). e010632–e010632. 46 indexed citations
5.
Forrest, Graeme N., Michael D. Gershon, Yan Zhou, et al.. (2014). Disseminated, Persistent, and Fatal Infection Due to the Vaccine Strain of Varicella-Zoster Virus in an Adult Following Stem Cell Transplantation. Clinical Infectious Diseases. 60(7). 1068–1074. 46 indexed citations
6.
Loughlin, Anita M., Colin D. Marchant, William G. Adams, et al.. (2012). Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine. 30(50). 7253–7259. 29 indexed citations
7.
Eidem, Benjamin W., Steven D. Colan, Irene H. Cheng, et al.. (2011). Abstract 10808: Left Ventricular Diastolic Dysfunction in HIV-Negative Infants Exposed In Utero to Antiretroviral Therapy from HIV-Positive Mothers: The Prospective NHLBI CHAART-I Study. Circulation. 124. 1 indexed citations
8.
Yen, Catherine, Kathleen Jakob, Mathew D. Esona, et al.. (2011). Detection of fecal shedding of rotavirus vaccine in infants following their first dose of pentavalent rotavirus vaccine. Vaccine. 29(24). 4151–4155. 55 indexed citations
9.
LaRussa, Philip. (2011). Pandemic Novel 2009 H1N1 Influenza: What Have We Learned?. Seminars in Respiratory and Critical Care Medicine. 32(4). 393–399. 49 indexed citations
10.
Gershon, Anne A., et al.. (2009). A PHASE I–II STUDY OF LIVE ATTENUATED VARICELLA-ZOSTER VIRUS VACCINE TO BOOST IMMUNITY IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN WITH PREVIOUS VARICELLA. The Pediatric Infectious Disease Journal. 28(7). 653–655. 26 indexed citations
11.
Beninger, Paul, et al.. (2008). The Safety Profile of Varicella Vaccine: A 10‐Year Review. The Journal of Infectious Diseases. 197(s2). S165–S169. 166 indexed citations
12.
Graham, Philip L., Philip LaRussa, & Katrin Kohl. (2007). Robust take following exposure to vaccinia virus: Case definition and guidelines of data collection, analysis, and presentation of immunization safety data. Vaccine. 25(31). 5763–5770. 2 indexed citations
13.
14.
Gershon, Anne A., Mahmoud M. Al‐Bassam, Sharon P. Steinberg, et al.. (2006). Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts. Proceedings of the National Academy of Sciences. 104(1). 208–212. 36 indexed citations
15.
Nicholson, Ouzama, Kristina N. Feja, Philip LaRussa, et al.. (2006). Nontuberculous Mycobacterial Infections in Pediatric Hematopoietic Stem Cell Transplant Recipients. The Pediatric Infectious Disease Journal. 25(3). 263–267. 17 indexed citations
16.
Ampofo, Krow, Lisa Saiman, Philip LaRussa, et al.. (2002). Persistence of Immunity to Live Attenuated Varicella Vaccine in Healthy Adults. Clinical Infectious Diseases. 34(6). 774–779. 55 indexed citations
17.
Sharrar, Robert G., Philip LaRussa, Sharon P. Steinberg, et al.. (2000). The postmarketing safety profile of varicella vaccine. Vaccine. 19(7-8). 916–923. 185 indexed citations
18.
LaRussa, Philip, Sharon Steinberg, François Meurice, & Anne A. Gershon. (1997). Transmission of Vaccine Strain Varicella‐Zoster Virus from a Healthy Adult with Vaccine‐Associated Rash to Susceptible Household Contacts. The Journal of Infectious Diseases. 176(4). 1072–1075. 57 indexed citations
19.
LaRussa, Philip, et al.. (1996). CLINICAL TRIALS IN IMMUNOCOMPROMISED INDIVIDUALS. Infectious Disease Clinics of North America. 10(3). 583–594. 35 indexed citations
20.
LaRussa, Philip. (1984). Perinatal Herpesvirus Infections. Pediatric Annals. 13(9). 659–670. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandra S. Chaves Breakdown of academic impact, for papers by Adriana Weinberg Breakdown of academic impact, for papers by Rafael Harpaz Breakdown of academic impact, for papers by Robin Broadhead Breakdown of academic impact, for papers by Barbara J. Kuter Breakdown of academic impact, for papers by Melinda Wharton Breakdown of academic impact, for papers by Anton M. van Loon Breakdown of academic impact, for papers by Javier Díez‐Domingo Breakdown of academic impact, for papers by Aisha O. Jumaan Breakdown of academic impact, for papers by Keith S. Reisinger
Rankless by CCL
2026